EP1032583A4 - Aktive immunisierung gegen durch angiogenese hervorgerufene antigene - Google Patents

Aktive immunisierung gegen durch angiogenese hervorgerufene antigene

Info

Publication number: EP1032583A4
Authority: EP; European Patent Office
Prior art keywords: angiotens; immunization against; active immunization; active; immunization
Prior art date: 1998-03-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP99911258A

Other languages

English (en)

French (fr)

Other versions

EP1032583A1 (de

Inventor

Daniel J Hicklin

Soldano Ferrone

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

New York Medical College

ImClone LLC

Original Assignee

New York Medical College

ImClone Systems Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-06

Filing date

1999-03-08

Publication date

2005-02-02

1999-03-08 Application filed by New York Medical College, ImClone Systems Inc filed Critical New York Medical College

2000-09-06 Publication of EP1032583A1 publication Critical patent/EP1032583A1/de

2005-02-02 Publication of EP1032583A4 publication Critical patent/EP1032583A4/de

Status Withdrawn legal-status Critical Current

Links

230000003053 immunization Effects 0.000 title 1
238000002649 immunization Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4244—Enzymes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Rheumatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

EP99911258A 1998-03-06 1999-03-08 Aktive immunisierung gegen durch angiogenese hervorgerufene antigene Withdrawn EP1032583A4 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US3672498A	1998-03-06	1998-03-06
US36724		1998-03-06
PCT/US1999/005164 WO1999045018A1 (en)	1998-03-06	1999-03-08	Active immunization against angiogenesis-associated antigens

Publications (2)

Publication Number	Publication Date
EP1032583A1 EP1032583A1 (de)	2000-09-06
EP1032583A4 true EP1032583A4 (de)	2005-02-02

Family

ID=21890263

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP99911258A Withdrawn EP1032583A4 (de)	1998-03-06	1999-03-08	Aktive immunisierung gegen durch angiogenese hervorgerufene antigene

Country Status (4)

Country	Link
EP (1)	EP1032583A4 (de)
AU (1)	AU2994599A (de)
CA (1)	CA2310252A1 (de)
WO (1)	WO1999045018A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20010102556A (ko) *	1999-03-11	2001-11-15	추후제출	암 및 과증식성 장애의 치료 조성물 및 치료방법
FR2796073B1 (fr) *	1999-07-07	2003-08-29	Centre Nat Rech Scient	Anticorps anti-idiotypiques des facteurs de croissance des fibroblastes et leur utilisation comme medicaments
US7087592B1 (en)	1999-08-23	2006-08-08	Entre Med, Inc.	Compositions comprising purified 2-methoxyestradiol and methods of producing same
US7094410B2 (en)	2002-03-02	2006-08-22	The Scripps Research Institute	DNA vaccine against proliferating endothelial cells and methods of use thereof
CU23178A1 (es) *	2002-04-15	2006-09-22	Ct Ingenieria Genetica Biotech	INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA
KR20050047518A (ko) *	2002-07-05	2005-05-20	듀크 유니버시티	혈관 면역요법
EP1633367A2 (de)	2003-05-28	2006-03-15	EntreMed, Inc.	Antiangiogene mittel
CA2558014A1 (en)	2004-03-12	2005-09-29	Entremed, Inc.	Antiangiogenic agents
CA2646065C (en)	2006-03-20	2014-01-14	Entremed, Inc.	Disease modifying anti-arthritic activity of 2-methoxyestradiol
WO2008006187A2 (en) *	2006-07-12	2008-01-17	Legeev, Yury V.	Protein complexes for prevention and treatment of diseases with angiogenesis disorders
CU24637B1 (es)	2019-12-24	2022-12-12	Ct Ingenieria Genetica Biotecnologia	Polipéptidos que comprenden mutantes del vegf-a humano con re-arreglos de puentes disulfuro y composiciones que los contienen

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0438803A2 (de) *	1990-01-26	1991-07-31	Immunomedics, Inc.	Impfstoffe gegen Krebs und Infektionskrankheiten
WO1994005329A1 (en) *	1992-08-31	1994-03-17	Jenner Technologies	Stimulation of an antitumor t-cell response using anti-idiotypic antibodies
WO1997023510A1 (fr) *	1995-12-21	1997-07-03	Centre National De La Recherche Scientifique	Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments
WO1997023237A1 (en) *	1995-12-22	1997-07-03	Immunomedics, Inc.	Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1979000160A1 (en) *	1977-09-28	1979-04-05	Nat Res Dev	Improvements in or relating to immunological preparations
US4778752A (en) *	1983-10-11	1988-10-18	Scripps Clinic And Research Foundation	Receptors specific for hapten-modified self proteins
US5703055A (en) *	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
KR920703114A (ko) *	1989-07-14	1992-12-17	원본미기재	접합체 백신을 위한 시토킨 및 호르몬 운반체
US5965132A (en) *	1992-03-05	1999-10-12	Board Of Regents, The University Of Texas System	Methods and compositions for targeting the vasculature of solid tumors
WO1993022343A1 (en) *	1992-05-01	1993-11-11	The Rockfeller University	Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom

1999
- 1999-03-08 AU AU29945/99A patent/AU2994599A/en not_active Abandoned
- 1999-03-08 EP EP99911258A patent/EP1032583A4/de not_active Withdrawn
- 1999-03-08 WO PCT/US1999/005164 patent/WO1999045018A1/en not_active Ceased
- 1999-03-08 CA CA002310252A patent/CA2310252A1/en not_active Abandoned

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0438803A2 (de) *	1990-01-26	1991-07-31	Immunomedics, Inc.	Impfstoffe gegen Krebs und Infektionskrankheiten
WO1994005329A1 (en) *	1992-08-31	1994-03-17	Jenner Technologies	Stimulation of an antitumor t-cell response using anti-idiotypic antibodies
WO1997023510A1 (fr) *	1995-12-21	1997-07-03	Centre National De La Recherche Scientifique	Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments
WO1997023237A1 (en) *	1995-12-22	1997-07-03	Immunomedics, Inc.	Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MARUYAMA HARUHIKO ET AL: "Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733", INTERNATIONAL JOURNAL OF CANCER, vol. 65, no. 4, 1996, pages 547 - 553, XP008039311, ISSN: 0020-7136 *
ORTEGA N ET AL: "MODULATION DE LA PROGRESSION TUMORALE PAR DES ANTICORPS ANTI-IDIOTYPIQUES DE FACTEURS ANGIOGENIQUES. MODULATION OF TUMOR PROGRESSION BY ANTI-IDIOTYPIC ANTIBODIES OF ANGIOGENIC FACTORS", COMPTES RENDUS DES SEANCES DE L'ACADEMIE DES SCIENCES. SERIE III: SCIENCES DE LA VIE, ELSEVIER, AMSTERDAM, NL, vol. 319, no. 5, 1 May 1996 (1996-05-01), pages 411 - 415, XP000601935, ISSN: 0764-4469 *
PLOUET J ET AL: "VEGF DEPENDENT TUMORAL PROGRESSION: SITMULATION BY ANTI VEGF IDIOTYPIC ANTIBODIES", JOURNAL OF CELLULAR BIOCHEMISTRY. SUPPLEMENT, A.R. LISS, NEW YORK, NY, US, no. SUPPL 18A, January 1994 (1994-01-01), pages 328, XP000602723, ISSN: 0733-1959 *
See also references of WO9945018A1 *

Also Published As

Publication number	Publication date
CA2310252A1 (en)	1999-09-10
EP1032583A1 (de)	2000-09-06
AU2994599A (en)	1999-09-20
WO1999045018A1 (en)	1999-09-10

Legal Events

Date	Code	Title	Description
2000-07-21	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-09-06	17P	Request for examination filed	Effective date: 20000524
2000-09-06	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE
2005-02-02	A4	Supplementary search report drawn up and despatched	Effective date: 20041217
2008-03-12	17Q	First examination report despatched	Effective date: 20080206
2009-11-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2009-12-30	18D	Application deemed to be withdrawn	Effective date: 20090707

Publication	Publication Date	Title
DE69829400D1 (de)	2005-04-21	Passive immunisierung gegen durch clostridium difficile verursachte krankheit
NO983141L (no)	2000-01-10	Antigene peptider
DE60235989D1 (de)	2010-05-27	Antikörper gegen opgl
DE69935574D1 (de)	2007-05-03	Antikörper gegen mensliches il-12
DE60228152D1 (de)	2008-09-25	Brennstoffzellensystem
DE69922087D1 (de)	2004-12-30	Brennstoffeinspritzdüse
ID25977A (id)	2000-11-16	Popok sekali pakai
ID24555A (id)	2000-07-27	Popok sekali pakai
ID23076A (id)	2000-02-03	Popok sekali pakai
DE19915874B8 (de)	2007-11-22	Kraftstoffeinspritzdüse
DE69918902D1 (de)	2004-09-02	Brennstoffinjektor
DE50112588D1 (de)	2007-07-19	Einspritzdüse
DE60205144D1 (de)	2005-09-01	Kraftstoffsystemteil
EP1310252A4 (de)	2009-06-10	Injektionen
DE69919777D1 (de)	2004-10-07	Kraftstoffinjektor
DE69925884D1 (de)	2005-07-28	Brennstoffeinspritzventil
ATE309314T1 (de)	2005-11-15	Celluligninbrennstoff
ID23083A (id)	2000-02-03	Popok sekali pakai
DE50009261D1 (de)	2005-02-24	Einspritzventil
DE59909449D1 (de)	2004-06-17	Kraftstoffeinspritzdüse
DE19983140T1 (de)	2001-05-17	Brennstoffeinspritzvorrichtung
DE60026628D1 (de)	2006-05-11	Einspritzventil
DE60220608D1 (de)	2007-07-26	Brennstoffzelle
DE10196521T1 (de)	2003-07-31	Brennstoff-System
EP1032583A4 (de)	2005-02-02	Aktive immunisierung gegen durch angiogenese hervorgerufene antigene